ÂÜÀòÂÒÂ×

Dr. White currently is the Drug Consulting Officer (DCO). He was the previous interim Chief Executive Officer (CEO) of Canget and stepped down in August 2019 for focusing on other business affairs as DCO. Dr. White received his PhD from the University of Virginia in Charlottesville in 1985. He has worked in the biotechnology sector since 1990, starting as a lab scientist and taking on positions of increasing responsibility up to the executive level. He has run drug discovery programs that resulted in deals with big Pharma and has had leadership roles on teams that have resulted in over 10 INDs being filed. He has negotiated numerous contracts and license agreements with companies such as Bayer, Nestles, Texas Inst, Archemix, and others. He also serves on the boards of or as an advisor to a number of drug discovery and medical device companies such as United Virology (a subsidiary of United Therapeutics Corp.), NovelMed, Microtransponder Inc, Cytonics Corp., Rosselini Scientific, and others. Dr. White has published numerous articles in high impact peer reviewed journals.